Enhancing Prostate Cancer Management With Wave Health (Digital Health Platform): A Feasibility Study

Author(s)

Hudson L1, Lashey M2, Roberts C3, Mitchell N3, Rose J1, Bajre M4
1Health Innovation Oxford and Thames Valley, Oxford, UK, 2Treatment Technologies & Insights, LA, CA, USA, 3Bayer Public Limited Company, Reading, UK, 4Health Innovation Oxford and Thames Valley, Oxford, OXF, UK

OBJECTIVES: This study utilizes the Lean Assessment Process (LAP) methodology to assess the feasibility and barriers associated with adopting Wave Health, a digital health platform (patient app and HCP portal) designed to revolutionize cancer management post-diagnosis. The technology harnesses electronic patient-reported outcomes (ePROs) to support patient self-management and enable care team remote monitoring and risk stratification.

METHODS: To better understand the unmet clinical need, a feasibility study was conducted with Health Innovation Oxford using the LAP methodology. LAP methodology focuses on generating an understanding of the potential benefits and acceptance of an innovation to facilitate adoption by the NHS. The study focused on understanding the potential benefits and acceptance of Wave Health for adoption by the NHS. With clinical pathway mapping related to prostate cancer management post-diagnosis, a pre read document to provided context about the technology and a discussion guide for semi-structured interviews was developed. Fifteen healthcare stakeholders from 7 NHS trusts who make treatment and/or management decisions within prostate cancer were interviewed. Responses were thematically analyzed to evaluate the clinical utility, usefulness, and barriers to adoption.

RESULTS: Stakeholders showcased an unmet need for an ePRO tool with Wave Health’s potential to enhance clinical efficiencies, including reducing administrative workload and improving patient-centered care. The main perceived utility was identified as a self-management tool to more effectively monitor and support patients remotely impacting short and long-term patient management. Stakeholders expressed interest in tailored patient feedback and triaged notifications of patient symptoms.

CONCLUSIONS: Positive response to Wave Health’s platform for patient-supported self-management highlights the need for innovative solutions in prostate cancer care and oncology. Localizing the technology for diverse patient groups is crucial, as stakeholders have identified. The LAP feasibility study has enabled a pilot within an NHS trust, gathering Real-World Evidence to support service implementation and adoption.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

MSR208

Topic

Health Technology Assessment, Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes, Value Frameworks & Dossier Format

Disease

Oncology

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×